SHH Healthcare Drug Manufacturers - Specialty & Generic 603567.SS

Heilongjiang ZBD Pharmaceutical Co., Ltd.

$ 4.68 -7.87 %

Heilongjiang ZBD Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm dedicated to the entire lifecycle of Traditional Chinese Medicine (TCM), from research and development to manufacturing and sales, exclusively within China. Its extensive product portfolio addresses a wide spectrum of health concerns, including conditions related to cardiovascular and cerebrovascular health, respiratory ailments, orthopedic issues, oncology, digestive disorders, anti-infective treatments, neuropsychiatric conditions, and genitourinary problems, among others. Established in 1996, the company maintains its headquarters in Hulin, China.

CEO: Jiujiang Yan - https://www.zbdzy.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

-

DCF

$ 4.56

Loading data...

603567.SS vs S&P500

Loading data...

No data available.

Quick ratio

1.03

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

-2.71

may indicate that the company is undervalued or has poor growth prospects.

EPS

-1.73

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

-23.68 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

-10.43 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

6.02

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.33

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

0.64

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

-6.36 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
3 indicates worrying financial health
Altman score
0.56 indicates a high risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.01 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.19 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.